GenMark Diagnostics (GNMK) Reports In-Line Q3 EPS

GenMark Diagnostics (NASDAQ: GNMK) reported Q3 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.28 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
• Jefferies Financial stock slips 3% as Fixed Income, Asset Management revenues fall
• Acuity Brands (AYI) Tops Q4 EPS by 11c